Brevan Howard Capital Management’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Buy
191,722
+152,368
+387% +$3.37M 0.03% 439
2026
Q1
$917K Buy
+39,354
New +$1.23M 0.01% 958
2025
Q3
Sell
-11,738
Closed -$720K 2007
2025
Q2
$720K Sell
11,738
-753
-6% -$42K ﹤0.01% 1213
2025
Q1
$725K Sell
12,491
-21,340
-63% -$1.35M 0.01% 610
2024
Q4
$1.81M Buy
+33,831
New +$1.66M 0.01% 305

Other funds holding DOCS

Brevan Howard Capital Management's DOCS Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Doximity (DOCS) stake by 387% in Q2 2026, buying an estimated $3.37M and bringing the position to 191,722 shares worth $3.98M. The position accounts for 0.03% of the portfolio, ranked #439.

Brevan Howard Capital Management first reported a position in DOCS in Q4 2024 and has held it in 5 quarters since. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Brevan Howard Capital Management held 191,722 shares of Doximity worth $3.98M as of Q2 2026.
  • Brevan Howard Capital Management bought 152,368 Doximity shares in Q2 2026, an estimated $3.37M.
  • Doximity made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #439 holding.
  • Brevan Howard Capital Management first reported a position in Doximity in Q4 2024 and has held it in 5 quarters since.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.